INTRODUCTION
During the course of gestation a large amount of iron is transferred against a concentration gradient rapidly and uinidirectionally from mother to fetus across the placenta (1) (2) (3) (4) (5) (6) (7) (8) (9) . Ferrokinetic studies in man (1, 2) and in experimental animals with hemochorial placentas (3) (4) (5) (6) (7) (8) show that the major placental transfer of iron occurs late in gestation. The exclusive souirce of this iron which is transferred to the fetus is the extremely stable transferrin-iron complex (the stability constant at physiologic pH and PCo2 is -1024 M-' [10] ) in the maternal plasma. Maternal transferrin which binds to placental tissue does not cross the placenta to the fetal circulation (11) . As gestation progresses, transferrin uptake by the placenta increases proportionately as the rate of iron delivery to the fetus increases (11) . Uptake Preliminary findings of this study were presented in part at the 17th International Congress of Hematology, Paris, France, July 1978.
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Received for publication 8 November 1978 and in revised form 21 January 1980. 1182 of both transferrin and iron is not affected by removal of the fetus, indicating that these placental functions are independent of fetal requirements (4) . Conse(luently, it has been proposed that the maternal transferrin-iron complex is taken up by receptors on the placental surface followed by removal of its iron. This iron is transported through the placenta and becomes associated with fetal transferrin in the fetal circulation (11) . The iron-depleted maternal transferrin is then returned to the maternal circulation enabling it to participate in ftirther cycles of plasma-to-placenta iron exchange.
Laurell and Morgan (12) postulated that the maternal transferrin-iron complex first attaches to specific receptors on the surface of the placenta before iron is removed from the transferrin, and van Bockxmeer et al. (13) identified a transferrin-binding protein in detergent extracts of rabbit placentas. Receptors have been inferred from the discrete patches of transferrin observed on the surface of human placenta microvilli by electron microscopic immunocytochemical methods (14) . By modifying the methods of N. C. Smith et al. (15) and C. H. Smith and co-workers (16, 17) we characterized a microvillous membrane vesicle preparation from human syncytiotrophoblast and showed that the vesicles were similar in shape, size, and microfilamentous content with those of intact placental microvilli. These vesicles were enriched in enzymes characteristic of plasmla membranes and were relatively devoid of enzymes characteristic of other organelles. Electron micrographs of membrane vesicles prepared for localization of transferrin by the peroxidase-antiperoxidase unlabeled antibody method showed that transferrin was specifically bound to the outer surface of the vesicles (16) . This isolated microvillous membrane preparation thus seemed ideal to examine transferrinbinding to specific receptors on the placental syncytiotrophoblast. In this paper we report on the interaction between human transferrin and specific receptors on the microvillous membrane of human placenta and the partial characterization of these transferrin receptors.
METHODS
Microvillous membrane preparation. Placentas were obtained immediately after delivery from women who had vaginal deliveries or elective cesarean sections at term. Microvillous membrane vesicles were prepared from these placentas by the method of Smith et al. (16) . The protein concentration of the final microvillous membrane suspension ranged from 2.5 to 6.0 mg/ml of suspension as measured by the Lowry et al. method (18) . In addition, 200 U of Trasylol (FBA Pharmaceuticals, Inc., New York) were added to the vesicles to minimize possible proteolytic activity. Microvillous membrane suspensions were studied within 4 h of preparation.
Labeling of proteins. Human apotransferrin (Sigma Chemical Co., St. Louis, Mo.) was saturated with iron according to the method of Harris and Aisen (19) and further purified by gel filtration on a Sephacryl S-200 column (2.5 x 75 cm) (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) equilibrated with phosphate-buffered saline, pH 7.4, and ion-exchange chromatography using DEAE-Sephacel (Pharmacia Fine Chemicals). The purity of the final product was >98% as determined by electrophoresis on 10% polyacrylamide gels at pH 8.3. Proteins were labeled with carrier-free [1'5I]-or ['31']sodium iodide (New England Nuclear, Boston, Mass.) using the iodine monochloride method of McFarlane (20) to give an average maximum of one iodine atom per protein molecule. Apotransferrin was prepared as described by Harris et al. (21) and labeled with carrier and radioactive iron 59FeC13 (New England Nuclear) in the form of its complex with nitrilotriacetic acid (Eastman Kodak, Rochester, N. Y.) according to the method of Harris and Aisen (19) in amounts equivalent to 95% of its calculated iron binding capacity.
Binding assays. Aliquots (100 ul) ofthe microvillous membrane suspension were diluted to a final volume of 1 ml with Hepes-saline solution, pH 7.4, containing radioactively labeled transferrin at 4°C. The reaction mixture was made up in polyearbonate centrifugation tubes (16 x 85 mm), which had previously been soaked in 5 mg/ml bovine serum albumin for at least 1 h. Failure to precoat the tubes with albumin resulted in significant adsorption of labeled transferrin to the tubes confirming the findings of Phillips (22) . All incubations were performed in a Dubnoff shaking water bath at 37°C. At predetermined time intervals, samples were removed from the incubator, placed on ice, and the reaction terminated by the addition of 6 ml ice-cold, enriched Hepes-buffered saline (0.2% bovine serum albumin, 0.1% glucose in Hepessaline, pH 7.4). The tubes were centrifuged for 15 For gel filtration studies columns (1.5 x 60 cm) containing Ultrogel ACA34 (LKB, Stockholm, Sweden) were equilibrated with 0.1% Teric 12A9 in 10 mM Hepes-saline buffer, pH 7.4. Aliquots (500 ,l) of membrane extracts were applied and eluted with the equilibration buffer. Constant volume fractions (by weight) were collected for total protein and radioactivity measurement. Columns were calibrated under identical elution conditions with proteins of known molecular weight and Stokes radii (Pharmacia Fine Chemicals, high and low molecular weight calibration kits). These two parameters for transferrin and its placental receptor complex were estimated from calibration plots of KAV vs. log molecular weight and V-log(KAV) vs. Stokes radius.
Aliquots (500 pl) obtained from either membrane extracts or gel filtration peaks were applied to linear sucrose density gradients (7- 
RESULTS
Effect of time on transferrin and iron uptake. Samples of microvillous membrane suspensions were incubated for various time intervals at 37°C with 59Fe-and 1251-labeled transferrin. The uptake of 1251-transferrin by the microvillous membrane preparation increased rapidly with the time of incubation and with the transferrin concentration in the incubation medium. Half-maximal binding was observed at <5 min ( Fig. lA) . At a fixed concentration of labeled transferrin in the incubation medium the timed uptake of the protein exhibited three distinct phases, viz., an "initial-binding" phase at zero time, a "progressive-binding" or "displacement" phase during the first 20 min of incubation, and a final "plateau" phase reached at -20 min. This plateau was maintained for the remainder of the incubation period, which indicates that a steady-state value in transferrin binding had been reached by -20 min and that the ability of the microvillous membrane preparation to bind transferrin was not diminished with continued incubation under these conditions. Similar results were observed with each series of incubations performed at fixed concentrations of transferrin over a wide range (1 to 100 jig/ml) in the incubation medium. The results (Fig. IA) also indicate that the placental membrane transferrin uptake increased in a nonlinear fashion with increasing concentrations of transferrin in the incubation medium. During these studies the fate of the 59Fe label presented as the specifically bound diferric complex with transferrin was also examined. The results (Fig. 1B) indicate that the binding of iron by the microvillous membrane preparations closely mirrored the uptake of transferrin as shown in Fig. lA . This parallel uptake suggests that the iron bound to the membrane suspensions was bound as the transferrin-iron complex. There was no significant accumulation of iron relative to transferrin by the membrane preparations with either increased incubation intervals or with increased transferrin concentrations in the incubation media (Fig. 1B) . Comparison of the curves shown in Fig. 1A and B indicates that at each time interval the molar ratio of bound iron to bound transferrin is close to a value of two for all the curves.
Transferrin binding to microvillous memnbrane preparations. Steady-state binding of 59Fe-and 1251_ labeled transferrin to aliquots of microvillous membrane suspensions was investigated at transferrin concentrations in the range of 1 to 800 ,ug/ml. To insure imiaximiial binding, incubation times of30 and 40 min were chosen for duplicate reaction mixtures. Control timed incubations were performed at fixed transferrin concentrations to verify that steady-state values were achieved. The results shown in Fig. 2 cpm/,ug protein) were incubated as described in the text. Bound 125I-labeled transferrin was measured (Methods) after 30 min (0) and 40 min (A) of incubation. In a parallel incubation it was determined that steady-state binding of transferrin had occurred by these incubation time intervals (cf. Fig. 1 Fig. 4 . The results (Fig. 4) FIGURE 4 Dissociation of 1251 -59Fe-labeled tranisferrin. NMicrovillous membranie suspensionis were incubated with 1251_ and 59Fe-labeled transferrin at a concentration of 32 (Fig. 6) . Likewise, human gammna globuilin produced no displacement (data not shown). However, unlabeled transferrin at a molar ratio twice that of the '25I-labeled transferriin displaced 50% of the 2351-labeledl transferrini fromii the high to low molectular weight peak (Fig. 6 ). (0) of an equimolar concentration of 131I-labeled human albumin. The molecular weight of human transferrin was assumed to be 77,000 and that of human albumin 67,000. Nonspecific transferrin binding to the placental microvillous membrane preparation (A) was determined from the uptake values of labeled transferrin in the presence of a large excess of unlabeled transferrin as described in the text. 131'-labeled albumin uptake (A) was also measured as ,ug albumin bound/mg microvillous membrane protein. The specific activity of '251-labeled transferrin was 3.2 x 103 cpm/,g protein, and that of 1311-labeled albumin was 9.8 x 103 cpm/,ug protein.
proteins run under identical conditions. Two components, one of apparent 89,000 mol wt and the other of 77,000 mol wt, predominated. The latter was identified as transferrin on the basis of its 1251 content and electrophoretic mobility relative to a transferrin standard run under identical conditions. Similar analysis by SDS-PAGE of the lower molecular weight peak (peak II) disclosed four components. The major component was serum albumin identified by its relative electrophoretic mobility (apparent 68,000 mol wt) and by affinity chromatography on Blue Sepharose CL-6B (Pharmacia Fine Chemicals) (29) . The other major component of peak II was transferrin. Two minor components with an apparent 60,000 and 55,000 mol wt were also detected.
Sucrose density gradient ultracentrifugation of receptor extracts was carried out in an attempt to achieve a higher degree of receptor purification. Teric extracts of microvillous membrane preparations that had been incubated with a saturating transferrin concentration (40 ,ug/ml) were applied to linear sucrose gradients and ultracentrifuged. The results are shown in Fig. 7 . The 1251-labeled transferrin peak of greater density (14.3% sucrose) represented the receptortransferrin complex, and the lower density peak (10.25% sucrose) corresponded to free transferrin. These results also indicate that, unlike in gel filtration studies, most of the labeled transferrin in the extract remained associated with its receptor. Receptor material taken from the center of the high density peak was analyzed by SDS-PAGE and showed that in addition to transferrin, three components of an apparent 215,000, 180,000, and 60,000 mol wt were present in the absence of f3-mercaptoethanol. In the presence of /-mercaptoethanol, transferrin and two components of 90,000 and 60,000 mol wt were present (Fig. 7, inset) . Material taken from the ultracentrifugation profile corresponding to the position of free transferrin contained in addition to transferrin a component of 60,000 mol wt (not shown). This method appeared to give a higher degree of receptor purification than gel filtration alone because many of the minor components previously observed were absent.
DISCUSSION
The concept of a transferrin receptor on the membranes of cells that take up transferrin and use its iron was first introduced by Jandl and co-workers (30, 31) in their pioneering studies on reticulocytes. Subsequent investigators have accumulated an increasing array of evidence, mainly kinetic, for the existence of transferrin receptors on reticulocytes (26, 32, 33) , marrow erythroblasts (34) , placental tissues (11), Friend erythroleukemic cells (35) , and lymphocytes (36) . Recently, transferrin receptors have been isolated from detergent extracts of reticulocyte membranes and partially characterized (13, 23, 27, 28, (37) (38) (39) (40) (41) (42) (43) (44) (27) , 190,000 (43), 175,000 (29) , 120,000 (39) , and 36,000 (42) in rabbit; 150,000 (45) and 95,000 (44) in rat reticulocytes. Most of this variation appears to be related to difficulties in the detergent fractionation of reticulocyte membrane components, although differences in species and methods for inducing reticulocytosis may also play a role. There is less variation in recent estimates of the affinity of transferrin for reticulocyte receptors. Values of 2.3 x 107 M'-for rabbit transferrin and intact rabbit reticulocytes (26), 4 .1 x 107 M-l for solubilized rabbit reticulocyte receptors (23) have been reported.
Another readily accessible tissue for study of transferrin receptors is the placenta. In these experiments on human placenta we present evidence for the existence of a specific transferrin receptor on the microvillous membrane of syncytiotrophoblast. Transferrin uptake was rapid and saturable. Saturation of a finite number of microvillous receptors was demonstrated in experiments where specific transferrin uptake was measuired under steady-state conditions over a wide (two orders of magnitude) range of transferrin concentration. At the physiologic concentration of transferrin expected in maternal plasma, the receptors were fully occupied. Transferrin binding was completely reversible. Labeled transferrin bound to microvillous membrane receptors under steady-state conditions could be rapidly and completely dissociated by competing unlabeled transferrin. Specificity for the interaction between transferrin and these receptors was indicated by the failure of albumin or gamma globulin to bind specifically to receptors or to compete with transferrin for the receptors in either intact membranes or soluble receptor preparations. rhe affinity of transferrin for its receptor was high (Ka = 2.2 x 107 M'-) and simnilar to affinity constants reported for reticulocytes (23, 26) . Only one class of incdependent homogenieous, satturable and high affinity receptors was presenit. These properties established conclusively that the placental membrane vesicles contain transferrin receptors.
Attempts at fuirther purification of the microvillous membrane transferrin receptor using nonionic detergent solubilization were carried out. Nonionic detergent solubilization preserved functional characteristics of the receptor such as specificity and reversibility of transferrin binding. Gel filtration sttudies indicated a Stokes radius of -77 A. Although une(quivocal conversion of this measurement to molecular weight cannot be made without additional information, the apparent value of' 310,000 mol wt for the transferrinreceptor complex is in reasonable agreement with that determined from the SDS-PAGE analysis of the dense peak on sucrose density gradient centrifugation. In the absence of ,8-mercaptoethanol a component with 215,000-mol wt was observed, which corresponids closely to a 230,000-mol wt calculated for the receptor when transferrin (77,000) is subtracted from the 310,000-mol wt comiiplex estimnatedl from gel filtration data. Froin analysis of the comiiponenits obtained from SDS-PAGE in the presence of 8-mercaptoethanol, our data do not permit fuirther precise identification of the subtuit comnposition on the transferrin receptor. However, since suibmission of this manuiscript, two papers have appeared and indicate that the placental receptor is a 90,000-mol wt glycoproteini (46, 47 No evidence was found in this study for the removal of iron from transferrin bound to microvillous membrane receptors even though a recent report (48) indicates that the preparation is capable of some metabolic activity as evidenced by glucocorticoid metabolism. More rigorous studies are required to assess the possibility of such iron removal under experimental conditions in which NAD+, ATP, or other energy sources and iron chelators are included.
Finally, the availability of large amounts of functional placental transferrin receptors in this microvillous membrane preparation should allow the assessment in human placenta of the comparative binding affinity of monoferric and diferric transferrin and the examination of the Fletcher-Huehns hypothesis (49) of selective binding of one species of monoferric transferrin. The recent observation of Leibman and Aisen (50) that iron on monoferric transferrin circulating in the plasma of normal human subjects has a selective orientation on one of the two iron binding sites of transferrin raises the possibility of selective placental binding of transferrin in pregnancy (49) . Since under our experimental conditions no metabolic conversion or scrambling of iron on transferrin seems possible with the microvillous membrane preparation, it appears ideal for the study of the biological implications of the FletcherHuehns hypothesis. 
